MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 93 filers reported holding MAGENTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $404 | -59.6% | 508 | -10.9% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 570 | -26.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 770 | +51.3% | 0.00% | – |
| Q1 2022 | $1,000 | -100.0% | 509 | -99.9% | 0.00% | – |
| Q4 2021 | $3,301,000 | -39.1% | 745,100 | 0.0% | 0.00% | – |
| Q3 2021 | $5,424,000 | -25.6% | 745,100 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $7,287,000 | -8.5% | 745,100 | +10.8% | 0.00% | 0.0% |
| Q1 2021 | $7,960,000 | +941.9% | 672,300 | +590.2% | 0.00% | – |
| Q4 2020 | $764,000 | +15.4% | 97,400 | 0.0% | 0.00% | – |
| Q3 2020 | $662,000 | -9.4% | 97,400 | 0.0% | 0.00% | – |
| Q2 2020 | $731,000 | -15.7% | 97,400 | -29.5% | 0.00% | – |
| Q1 2020 | $867,000 | -58.6% | 138,112 | 0.0% | 0.00% | – |
| Q4 2019 | $2,094,000 | +47.8% | 138,112 | 0.0% | 0.00% | – |
| Q3 2019 | $1,417,000 | -21.5% | 138,112 | +12.9% | 0.00% | – |
| Q2 2019 | $1,804,000 | – | 122,298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 8,008,204 | $50,292,000 | 45.98% |
| Casdin Capital, LLC | 2,971,034 | $18,658,000 | 1.98% |
| Alphabet Inc. | 3,339,138 | $20,970,000 | 1.38% |
| Opaleye Management Inc. | 434,712 | $2,730,000 | 0.72% |
| Bleichroeder LP | 251,875 | $1,582,000 | 0.41% |
| Eventide Asset Management | 1,789,646 | $11,239,000 | 0.36% |
| HARVARD MANAGEMENT CO INC | 332,610 | $2,089,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 4,059,789 | $25,495,000 | 0.31% |
| Leap Investments LP | 12,600 | $79,000 | 0.12% |
| Aries Wealth Management | 12,000 | $77,000 | 0.06% |